4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis

dc.contributor.authorde Almeida, Ana Carolina [UNESP]
dc.contributor.authorMarques, Otavio Cabral
dc.contributor.authorArslanian, Christina
dc.contributor.authorCondino-Neto, Antonio
dc.contributor.authorXimenes, Valdecir Farias [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-20T13:26:59Z
dc.date.available2014-05-20T13:26:59Z
dc.date.issued2011-06-25
dc.description.abstractApocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved.en
dc.description.affiliationUniv Estadual Paulista, UNESP, Fac Ciencias, Dept Quim, Bauru, SP, Brazil
dc.description.affiliationUniv São Paulo, Inst Ciencias Biomed, BR-05508000 São Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, UNESP, Fac Ciencias, Dept Quim, Bauru, SP, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipIdFAPESP: 08/53458-6
dc.format.extent445-453
dc.identifierhttp://dx.doi.org/10.1016/j.ejphar.2011.03.043
dc.identifier.citationEuropean Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011.
dc.identifier.doi10.1016/j.ejphar.2011.03.043
dc.identifier.fileWOS000291623600028.pdf
dc.identifier.issn0014-2999
dc.identifier.lattes4066413997908572
dc.identifier.urihttp://hdl.handle.net/11449/8788
dc.identifier.wosWOS:000291623600028
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofEuropean Journal of Pharmacology
dc.relation.ispartofjcr3.040
dc.relation.ispartofsjr1,057
dc.rights.accessRightsAcesso aberto
dc.sourceWeb of Science
dc.subjectApocyninen
dc.subjectNeutrophilen
dc.subjectMyeloperoxidaseen
dc.subjectNADPH oxidaseen
dc.subjectTNF alphaen
dc.subjectPhagocytosisen
dc.title4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosisen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
unesp.author.lattes4066413997908572
unesp.author.orcid0000-0003-2356-1700[2104]
unesp.author.orcid0000-0002-4462-3192[1036]
unesp.author.orcid0000-0002-3810-8530[827]
unesp.author.orcid0000-0002-1119-6614[275]
unesp.author.orcid0000-0003-1216-5235[2126]
unesp.author.orcid0000-0002-6109-3023[1650]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências, Baurupt
unesp.departmentQuímica - FCpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
WOS000291623600028.pdf
Tamanho:
1.53 MB
Formato:
Adobe Portable Document Format

Licença do Pacote

Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: